IART
Integra LifeSciences Holdings
13.40$
+3.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +119.5% | -73.2% | +156.4% | -44.3% | +125.7% | -122.2% | – | +358.6% | -71.1% | -17.0% | +132.6% | – | |
| – | -0.1% | +0.1% | +20.3% | -2.2% | +4.5% | -1.1% | +1.4% | +2.2% | -0.2% | +0.0% | -0.8% | – | |
| – | +6.1% | -3.3% | +29.4% | -39.5% | +63.2% | -73.9% | +183.2% | +5.4% | +4.6% | -11.5% | -200.0% | – | |
| – | – | -331.4% | – | +2,289.4% | -153.5% | – | – | – | -163.2% | – | – | – | |
| – | +87.6% | -37.0% | +92.1% | -0.2% | +33.4% | -26.9% | -30.3% | -24.8% | +107.3% | -52.7% | +0.0% | – | |
| – | +643.5% | -5.7% | +497.0% | -96.8% | -59.1% | +745.4% | -39.7% | -28.0% | +123.9% | -57.5% | +191.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.7% | +894.3% | +1,501.5% | -99.7% | +1,345.0% | – | – | -10.0% | -31.2% | – | – | – | |
| – | – | – | – | – | -77.0% | – | -107.6% | +233.8% | – | -63.8% | -26.9% | – | |
| – | -86.1% | – | -126.1% | -78.8% | -64.1% | – | -159.8% | -51.5% | – | -65.9% | -119.0% | – | |
| – | – | +11,716.6% | -219.4% | – | – | -123.3% | – | – | -79.9% | -38.5% | -1,414.8% | – | |
| – | +149.9% | -99.1% | +3,574.9% | -167.0% | – | -459.1% | – | – | -176.1% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.